Found 58 matching trials
Apalutamide and Abiraterone Acetate in African American and Caucasian Men With Metastatic Castrate Resistant Prostate Cancer PHASE2 The primary goal is to prospectively estimate the median PFS of African Ame...
Show More Location
Tulane University
Learn More & Join Trial
A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPC PHASE3 The purpose of this study is to determine if the addition of apalutamide to...
Show More Status
Active Not Recruiting
Location
Multiple Locations
Learn More & Join Trial
Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial PHASE3 This phase III trial studies whether adding apalutamide to the usual treatm...
Show More Status
Active Not Recruiting
Location
Cancer Center at Saint Joseph's
Learn More & Join Trial
14C-ARN-509 Microtracer Label AME and Absolute BA Study PHASE1 This is study in healthy human volunteers to determine the absorption, meta...
Show More Location
PRA - Clinical Research Unit, University Medical Centre Groningen
Learn More & Join Trial
Androgen Receptor Antagonist ARN-509 With or Without Abiraterone Acetate, Gonadotropin-Releasing Hormone Analog, and Prednisone in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery PHASE2 This randomized phase II trial studies how well androgen receptor antagonis...
Show More Status
Active Not Recruiting
Location
Yale Cancer Center
Learn More & Join Trial
Apalutamide and Gonadotropin-Releasing Hormone Analog With or Without Abiraterone Acetate in Treating Participants With Prostate Cancer PHASE2 This phase II trial studies how well apalutamide and gonadotropin-releasing...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial
Advanced ChemoHormonal Therapy for Treatment Naive Metastatic Prostate Cancer PHASE2 This phase II trial studies how well the combination of apalutamide, abirat...
Show More Status
Active Not Recruiting
Location
OHSU Knight Cancer Institute
Learn More & Join Trial
Neoadjuvant Apalutamide (ARN509) and Radical Prostatectomy in Treatment of Intermediate to High Risk Prostate Cancer PHASE2 This is an investigator-initiated phase II single arm trial, combining neoa...
Show More Location
Department of Urology
Learn More & Join Trial
A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer PHASE1 The purpose of this study is to investigate potential drug-drug interaction...
Show More Status
Active Not Recruiting
Location
Multiple Locations
Learn More & Join Trial
RE-sensitizing With Supraphysiologic Testosterone to Overcome REsistance (The RESTORE Study) PHASE2 Single-arm, single site, open label study of the effects of parenteral test...
Show More Location
Sibley Memorial Hospital
Learn More & Join Trial